Hepatitis Forums
Hepatitis C Main Forums => On Hepatitis C Treatment => Topic started by: mcmaklin on August 19, 2017, 07:56:49 am
-
Hello, I have not been here for a while.
As you maybe know my story is that I have relapsed a month after treatment Viekira+Exviera without Riba. Genotype 1b, now F1 maybe F2. After relapsing I have been found L31M and Q54H (still do not know much about the last one).
Now I am waiting for the newest Abbvie Mavyret or the Vosevi.
I am in UK and in Poland (in Poland I doubt will get the Vosevi).
I need some good data, as probavbly there are no many patients who have L31M.
1. WHICH OF THEM IS BETTER FOR ME? My consultant is thinking of Mavyret. Any data?
2. And do I need to take Riba?
3. Do you know a situation in UK?
thank you